ONLINE DATABASE SEARCH - OI-LS-296-MEMO
1. 43421 OI-LS-296; EMBASE-OI-5/18/2004
Synthesis of new fluoroquinolones and evaluation of their in vitro activity on Toxoplasma gondii and Plasmodium spp.
Anquetin, G, Rouquayrol, M, Mahmoudi, N, Santillana-Hayat, M, Gozalbes, R, Greiner, J, Farhati, K, Derouin, F, Guedj, R, and Vierling, P
Bioorganic & Medicinal Chemistry Letters 2004. 14(11): 2773-2776
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4C76C06-2/2/3f495f5098ef5e012d311ad9030c3de2
2. 43422 OI-LS-296; PUBMED-OI-5/18/2004
A Novel Class of Phosphonate Nucleosides. 9-[(1-Phosphonomethoxycyclopropyl)methyl]guanine as a Potent and Selective Anti-HBV Agent
Choi, JR, Cho, DG, Roh, KY, Hwang, JT, Ahn, S, Jang, HS, Cho, WY, Kim, KW, Cho, YG, Kim, J, and Kim, YZ
J Med Chem 2004. 47(11): 2864-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15139764&dopt=abstract
3. 43423 OI-LS-296; PUBMED-OI-5/18/2004
A microplate indicator-based method for determining the susceptibility of multidrug-resistant Mycobacterium tuberculosis to antimicrobial agents
Morcillo, N, Di, Giulio B, Testani, B, Pontino, M, Chirico, C, and Dolmann, A
Int J Tuberc Lung Dis 2004. 8(2): 253-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15139456&dopt=abstract
4. 43424 OI-LS-296; PUBMED-OI-5/18/2004
Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C
Arguedas, M
Pharmacoeconomics 2004. 22(7): 477-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15137884&dopt=abstract
5. 43425 OI-LS-296; EMBASE-OI-5/18/2004
Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis
Schaeffer, Merrill L, Carson, Jeffrey D, Kallender, Howard, and Lonsdale, JTJohn T
Tuberculosis 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6WXK-4CB08V1-1/2/9538bc63a2774edb592168b04cbc553d
6. 43426 OI-LS-296; PUBMED-OI-5/18/2004
A pncA polymorphism to differentiate between Mycobacterium bovis and Mycobacterium tuberculosis
Barouni, AS, Augusto, CJ, Lopes, MT, Zanini, MS, and Salas, CE
Mol Cell Probes 2004. 18(3): 167-70
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15135450&dopt=abstract
7. 43427 OI-LS-296; EMBASE-OI-5/18/2004
Phosphonate inhibitors of antigen 85C, a crucial enzyme involved in the biosynthesis of the Mycobacterium tuberculosis cell wall
Gobec, Stanislav, Plantan, Ivan, Mravljak, Janez, Wilson, Rosalind A, Besra, Gurdyal S, and Kikelj, Danijel
Bioorganic & Medicinal Chemistry Letters 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4CBV260-4/2/33c37309ec021da3efd490e6c69e56c3
8. 43428 OI-LS-296; EMBASE-OI-5/18/2004
In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis
Fattorini, Lanfranco, Gennaro, Renato, Zanetti, Margherita, Tan, Dejiang, Brunori, Lara, Giannoni, Federico, Pardini, Manuela, and Orefici, Graziella
Peptides 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T0M-4CBW8FD-3/2/4d829492157cb3169f6c89990986c6fb
9. 43429 OI-LS-296; PUBMED-OI-5/18/2004
Molecular Modeling and Simulation of Mycobacterium tuberculosis Cell Wall Permeability
Hong, X and Hopfinger, AJ
Biomacromolecules 2004. 5(3): 1066-77
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15132701&dopt=abstract
10. 43430 OI-LS-296; PUBMED-OI-5/18/2004
New single-isomer compounds on the horizon
Gal, J
CNS Spectr 2002. 7(4 Suppl): 45-54
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15131493&dopt=abstract
11. 43431 OI-LS-296; PUBMED-OI-5/18/2004
Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model
Pandey, R and Khuller, GK
J Antimicrob Chemother 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15128731&dopt=abstract
12. 43432 OI-LS-296; PUBMED-OI-5/18/2004
Report from the 11th conference on retroviruses and opportunistic infections. Microbicides
Zuger, A
AIDS Clin Care 2004. 16(4): 35
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15124589&dopt=abstract
13. 43433 OI-LS-296; PUBMED-OI-5/18/2004
Report from the 11th conference on retroviruses and opportunistic infections. Hepatitis
Albrecht, H
AIDS Clin Care 2004. 16(4): 32-3
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15124586&dopt=abstract
14. 43434 OI-LS-296; PUBMED-OI-5/18/2004
Report from the 11th conference on retroviruses and opportunistic infections. New drugs
Sax, PE
AIDS Clin Care 2004. 16(4): 29
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15124584&dopt=abstract
15. 43435 OI-LS-296; EMBASE-OI-5/18/2004
Selective anti-Toxoplasma gondii activities of azasterols
Dantas-Leite, Lucas, Urbina, Julio A, de Souza, Wanderley, and Vommaro, Rossiane C
International Journal of Antimicrobial Agents 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T7H-4C838FH-1/2/03c766ec0118bea3810e342b216f02b4
16. 43436 OI-LS-296; PUBMED-OI-5/18/2004
A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii
Carey, KL, Westwood, NJ, Mitchison, TJ, and Ward, GE
Proc Natl Acad Sci U S A 2004. 101(19): 7433-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15123807&dopt=abstract
17. 43437 OI-LS-296; EMBASE-OI-5/18/2004
Synthesis and study of antibacterial and antifungal activities of novel 1-[2-(benzoxazol-2-yl)ethoxy]- 2,6-diarylpiperidin-4-ones
Ramalingan, C, Balasubramanian, S, Kabilan, S, and Vasudevan, M
European Journal of Medicinal Chemistry 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6VKY-4C2NPGV-2/2/abda157383071e8d389592ab723e08d0
18. 43438 OI-LS-296; PUBMED-OI-5/18/2004
Proteomic approach identifies HSP27 as an interacting partner of the hepatitis C virus NS5A protein
Choi, YW, Tan, YJ, Lim, SG, Hong, W, and Goh, PY
Biochem Biophys Res Commun 2004. 318(2): 514-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15120631&dopt=abstract
19. 43439 OI-LS-296; EMBASE-OI-5/18/2004
New 6-nitroquinolones: synthesis and antimicrobial activities
Sbardella, Gianluca, Mai, Antonello, Artico, Marino, Setzu, Maria Giovanna, Poni, Graziella, and La Colla, Paolo
Il Farmaco 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6VJ8-4C2R61S-4/2/377755492dd33ebd730a012bfa9b0ad8
20. 43440 OI-LS-296; EMBASE-OI-5/18/2004
Significant accumulations of cathepsin B and prolylendopeptidase in inflammatory focus of delayed-type hypersensitivity induced by Mycobacterium tuberculosis in mice*1
Kakegawa, Hisao, Matano, Yuko, Inubushi, Tomoko, and Katunuma, Nobuhiko
Biochemical and Biophysical Research Communications 2004. 316(1): 78-84
HYPERLINK: http://www.sciencedirect.com/science/article/B6WBK-4BS0D6C-4/2/b31aac65e72ef1ec2d1e5ae0bd716993
21. 43441 OI-LS-296; PUBMED-OI-5/18/2004
Pegasys-Copegus combination treats both HIV and hepatitis C
Anon
AIDS Read 2004. 14(4): 164
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15116695&dopt=abstract
22. 43442 OI-LS-296; PUBMED-OI-5/18/2004
Peptide-based inhibitors of the hepatitis C virus NS3 protease: structure-activity relationship at the C-terminal position
Rancourt, J, Cameron, DR, Gorys, V, Lamarre, D, Poirier, M, Thibeault, D, and Llinas-Brunet, M
J Med Chem 2004. 47(10): 2511-22
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15115394&dopt=abstract
23. 43443 OI-LS-296; PUBMED-OI-5/18/2004
Developing RNase P ribozymes for gene-targeting and antiviral therapy
Trang, P, Kim, K, and Liu, F
Cell Microbiol 2004. 6(6): 499-508
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15104592&dopt=abstract
24. 43444 OI-LS-296; PUBMED-OI-5/18/2004
Antiviral flavonoids from the seeds of Aesculus chinensis
Wei, F, Ma, SC, Ma, LY, But, PP, Lin, RC, and Khan, IA
J Nat Prod 2004. 67(4): 650-3
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15104496&dopt=abstract
25. 43445 OI-LS-296; EMBASE-OI-5/18/2004
Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue
Bidanset, Deborah J, Rybak, Rachel J, Hartline, Caroll B, and Kern, Earl R
Antiviral Research 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2H-4C47FW1-1/2/88769d5f00948ba0108712fb59e6d538
26. 43446 OI-LS-296; EMBASE-OI-5/18/2004
In vitro-in vivo antifungal evaluation and structure-activity relationships of 3H-1,2-dithiole-3-thione derivatives
Giannini, Fernando A, Aimar, Mario L, Sortino, Maximiliano, Gomez, Roxana, Sturniollo, Alejandro, Juarez, Americo, Zacchino, Susana, de Rossi, Rita H, and Enriz, Ricardo D
Il Farmaco 2004. 59(4): 245-254
HYPERLINK: http://www.sciencedirect.com/science/article/B6VJ8-4BSVJMY-1/2/164cd7ffc637af703b28efb4e533d0b9
27. 43447 OI-LS-296; EMBASE-OI-5/18/2004
Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus
Choi, Jung-Hyun, Brummer, Elmer, and Stevens, David A
Microbes and Infection 2004. 6(4): 383-389
HYPERLINK: http://www.sciencedirect.com/science/article/B6VPN-4BRSDJP-2/2/3146bc9a0bfe2254065eebd0f0857715
28. 43448 OI-LS-296; EMBASE-OI-5/18/2004
The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host
Michel, Detlef and Mertens, Thomas
Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 2004. 1697(1-2): 169-180
HYPERLINK: http://www.sciencedirect.com/science/article/B73DJ-4B5J89S-4/2/fb1c47c2b71b846c2e5e8ebeb4eb8308
29. 43449 OI-LS-296; WOS-OI-5/09/2004
Lethal mutagens: broad-spectrum antivirals with limited potential for development of resistance?
Freistadt, MS, Meades, GD, and Cameron, CE
DRUG RESIST UPDATE 2004. 7(1): 19-24
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220829300004
30. 43450 OI-LS-296; WOS-OI-5/09/2004
Methylation of acridin-9-ylthioureas. Structure, fluorescence and biological properties of products
Bernat, J, Balentova, E, Kristian, P, Imrich, J, Sedlak, E, Danihel, I, Bohm, S, Pronayova, N, Pihlaja, K, and Klikad, KD
COLLECT CZECH CHEM C 2004. 69(4): 833-849
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220854200008
31. 43451 OI-LS-296; EMBASE-OI-5/18/2004
Synthesis and antiviral evaluation of benzimidazoles, quinoxalines and indoles from dehydroabietic acid
Fonseca, Tatiana, Gigante, Barbara, Marques, MMatilde, Gilchrist, Thomas L, and De Clercq, Erik
Bioorganic & Medicinal Chemistry 2004. 12(1): 103-112
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF8-4B4YTBX-8/2/b4d4fe8176ec5394d56c0b70fdb49254
32. 43452 OI-LS-296; EMBASE-OI-5/18/2004
28 Inhibition of hepatitis C virus subgenomic replication by constitutive transport element (CTE)-linked ribozymes directed against the HCV internal ribosomal entry site (IRES) and the 3' untranslated region (UTR)
Jarczak, D, Korf, M, Manns, MP, and Krueger, M
Journal of Hepatology 2004. 40(Supplement 1): 10-11
HYPERLINK: http://www.sciencedirect.com/science/article/B6W7C-4C5WW3G-11/2/2ceae737d9b61dfc3f06d09ef63224d1
33. 43453 OI-LS-296; EMBASE-OI-5/18/2004
First clinical results for a novel antiviral treatment for hepatitis C: A phase I/II dose escalation trial assessing tolerance, pharmacokinetics, and antiviral activity of NM283
Godofsky, E, Afdhal, N, Rustgi, V, Shick, L, Duncan, L, Zhou, XJ, Chao, G, Fang, C, Fielman, B, Myers, M, and Brown, NA
Journal of Hepatology 2004. 40(Supplement 1): 35
HYPERLINK: http://www.sciencedirect.com/science/article/B6W7C-4C5WW3G-3F/2/686934c31e32e9f6b1a426c8533fb3e3
34. 43454 OI-LS-296; WOS-OI-5/09/2004
Biomimetic chemical catalysts in the oxidative activation of drugs
Bernadou, J and Meunier, B
ADV SYNTH CATAL 2004. 346(2-3): 171-184
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220763400008
35. 43455 OI-LS-296; WOS-OI-5/16/2004
Nitric oxide inhibition after Toxoplasma gondii infection of chicken macrophage cell lines
Guillermo, LVC and DaMatta, RA
POULTRY SCI 2004. 83(5): 776-782
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221017300010
36. 43456 OI-LS-296; WOS-OI-5/16/2004
Clinical features, diagnosis, and management of multiple drug-resistant tuberculosis since 2002
Drobniewski, F, Balabanova, Y, and Coker, R
CURR OPIN PULM MED 2004. 10(3): 211-217
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220972400010
37. 43457 OI-LS-296; WOS-OI-5/16/2004
Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis
Sougakoff, W, Rodrigue, M, Truffot-Pernot, C, Renard, M, Durin, N, Szpytma, M, Vachon, R, Troesch, A, and Jarlier, V
CLIN MICROBIOL INFEC 2004. 10(4): 289-294
HYPERLINK:
http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220899300003